The present invention relates to a method and apparatus for applying a negative pressure. In particular, but not exclusively, the present invention relates to the application of a negative pressure to a wound site in the application of topical negative pressure at the wound site.
There is much prior art available relating to the provision of apparatus and methods of use thereof for the application of topical negative pressure (TNP) therapy to wounds together with other therapeutic processes intended to enhance the effects of the TNP therapy. Examples of such prior art include those listed and briefly described below.
TNP therapy (sometimes referred to as Vacuum Assisted Closure or negative pressure wound therapy) assists in the closure and healing of wounds by reducing tissue oedema; encouraging blood flow and granulation of tissue; removing excess exudates and may reduce bacterial load and thus, infection to the wound. Furthermore, TNP therapy permits less outside disturbance of the wound and promotes more rapid healing.
In International patent application, WO 2004/037334, which is incorporated herein by reference, apparatus, a wound dressing and a method for aspirating, irrigating and cleansing wounds are described. In very general terms, the application describes the treatment of a wound by the application of TNP therapy for aspirating the wound together with the further provision of additional fluid for irrigating and/or cleansing the wound, which fluid, comprising both wound exudates and irrigation fluid, is then drawn off by the aspiration means and circulated through means for separating the beneficial materials therein from deleterious materials. The materials which are beneficial to wound healing are recirculated through the wound dressing and those materials deleterious to wound healing are discarded to a waste collection bag or vessel.
In International patent application, WO 2005/04670, which is incorporated herein by reference, apparatus, a wound dressing and a method for cleansing a wound using aspiration, irrigation and cleansing are described. Again, in very general terms, the invention described in this document utilises similar apparatus to that in WO 2004/037334 with regard to the aspiration, irrigation and cleansing of the wound, however, it further includes the important additional step of providing heating means to control the temperature of that beneficial material being returned to the wound site/dressing so that it is at an optimum temperature, for example, to have the most efficacious therapeutic effect on the wound.
However, the above described apparatus and methods are generally only applicable to a patient when hospitalised as the apparatus used is complex, needing people having specialist knowledge in how to operate and maintain the apparatus, and also relatively heavy and bulky, not being adapted for easy mobility outside of a hospital environment by a patient, for example.
Some patients having relatively less severe wounds which do not require continuous hospitalisation, for example, but whom nevertheless would benefit from the prolonged application of TNP therapy, could be treated at home or at work subject to the availability of an easily portable and maintainable TNP therapy apparatus. To this end GB-A-2 307 180 describes a portable TNP therapy unit which may be carried by a patient and clipped to belt or harness. A negative pressure can thus be applied at a wound site.
However, this portable apparatus is still relatively bulky, and may require monitoring of the patient by a trained caregiver. Furthermore, such portable therapy units commonly have reduced capacity to deal with fluid flow rates into a wound cavity caused by leaks. This leads to a greater number of alarms being raised due to an inability to maintain the desired negative pressure at the wound site in the presence of leaks.
Another problem associated with portable apparatus is that on occasion an onboard power source such as a battery pack is used rather than a continuous connection to a power source such as a mains power source. It will be appreciated that such a battery pack has only a limited power resource and therefore TNP therapy can on occasion be halted prior to a desired moment in time because of power failure.
Another problem associated with therapy units which can be utilised by a patient alone without the need for skilled technical assistants is that from time to time warning lights or warning alarms may be initiated when a desired therapy can not be maintained or initiated. This can be distressing for a patient who may not understand the meaning of the cues.
A still further problem associated with the apparatus used to provide TNP therapy is that from time to time a motor associated with a pump which generates a negative pressure will start up or stop. The change in volume coming from the therapy unit can be a cause of concern to a patient.
It is an aim of certain embodiments of the present invention to at least partly mitigate one or more of the above-mentioned problems.
It is an aim of certain embodiments of the present invention to provide a method for controlling the provision of a desired negative pressure at a wound site to aid in wound closure and healing.
It is an aim of certain embodiments of the present invention to provide a pressure control apparatus that avoids the generation of unnecessary alarms in the presence of transient leaks.
It is an aim of certain embodiments of the present invention to provide a pressure control apparatus that helps extend battery power lifetime.
It is an aim of certain embodiments of the present invention to provide a pressure control apparatus that reduces a number of pump motor start-up or power down operations.
According to a first aspect of the present invention there is provided apparatus for dressing a wound for the application of topical negative pressure at a wound site, comprising:
According to a second aspect of the present invention there is provided a method of applying topical negative pressure (TNP) at a wound site, comprising the steps of:
According to a third aspect of the present invention there is provided an apparatus for applying negative pressure to a wound, comprising:
In some embodiments, the controller is further configured to: deactivate the source of negative pressure when the first desired negative pressure has not been generated under the dressing after activating the source of negative pressure for a first number of times exceeding a first threshold.
In some embodiments, the controller is further configured to: when the first number of times exceeds the first threshold, deactivate the source of negative pressure for a third time interval.
In some embodiments, the apparatus further comprises: a switch configured to signal to the controller to activate or deactivate the source of negative pressure; and the controller is further configured to, upon expiration of the third time interval or upon receiving a signal to activate the source of negative pressure from the switch, activate the source of negative pressure to generate the first desired negative pressure under the dressing.
In some embodiments, the apparatus further comprises: an indicator, wherein the controller is further configured to activate the indicator when the first number of times exceeds the first threshold.
In some embodiments, the controller is further configured to: deactivate the indicator upon expiration of the third time interval or receiving a signal to activate the source of negative pressure from the switch.
In some embodiments, the indicator indicates a leak in the seal.
In some embodiments, the controller is further configured to:
In some embodiments, the first and second desired negative pressure are the same.
In some embodiments, the second desired negative pressure is less than the first desired negative pressure.
In some embodiments, the controller is further configured: to deactivate the source of negative pressure if the negative pressure under the dressing has reached the second desired negative pressure or if the negative pressure under the dressing has not reached the second desired negative pressure upon expiration of a fourth time interval.
In some embodiments, if the negative pressure under the dressing has not reached the second desired negative pressure upon expiration of the fourth time interval, the controller is further configured to, upon expiration of the second time interval, activate the source of the negative pressure to generate the first desired negative pressure under the dressing.
In some embodiments, the controller is further configured to: activate the source of the negative pressure to generate the first desired negative pressure under the dressing if the controller has activated the source of negative pressure to reach the second desired negative pressure for a second number of times less than a second threshold.
In some embodiments, the controller is further configured to:
In some embodiments, the controller is further configured to:
In some embodiments, the duty cycle comprises an amount, proportion, or percentage of time the source of negative pressure is active over a period of time.
In some embodiments, the controller is further configured to: calculate a number of duty cycles that exceed the first duty cycle threshold and deactivate the source of negative pressure when the number of duty cycles that exceed the first duty cycle threshold exceeds a second duty cycle threshold.
In some embodiments, the controller is further configured to calculate a number of consecutive duty cycles that exceed the first duty cycle threshold.
In some embodiments, the second duty cycle threshold comprises 30 minutes.
In some embodiments, the controller is further configured: to upon expiration of the third time interval or upon receiving the signal from the switch to active the source of negative pressure, activate the source of negative pressure to generate the first desired negative pressure under the dressing.
In some embodiments, the source of negative pressure comprises a pump.
In some embodiments, the apparatus further comprises: a pressure sensor configured to sense pressure under the dressing and to communicate the sensed pressure to the controller.
In some embodiments, the apparatus further comprises: a one-way valve coupled between an inlet and the source of negative pressure, wherein the inlet is in fluid communication with the dressing.
In some embodiments, the source of negative pressure comprises: a valve configured to connect the port to an external source of negative pressure.
In some embodiments, the controller is further configured to: activate or deactivate the source of negative pressure by operating the valve.
According to a fourth aspect of the present invention there is provided a method of applying negative pressure to a wound, comprising:
In some embodiments, the method further comprises: deactivating the source of negative pressure when the first desired negative pressure has not been generated under the dressing after activating the source of negative pressure for a first number of times exceeding a first threshold.
In some embodiments, the method further comprises: deactivating the source of negative pressure for a third time interval when the first number of times exceeds the first threshold.
In some embodiments, the method further comprises: activating the source of negative pressure to generate the first desired negative pressure under the dressing upon expiration of the third time interval or upon receiving a signal to activate the source of negative pressure from a switch.
In some embodiments, the method further comprises: indicating to a user when the first number of times exceeds the first threshold.
In some embodiments, the method further comprises: stopping the indication upon expiration of the third time interval or receiving a signal to activate the source of negative pressure from the switch.
In some embodiments, the indicating indicates a leak in the seal.
In some embodiments, the method further comprises:
In some embodiments, the first and second desired negative pressure are the same.
In some embodiments, the second desired negative pressure is less than the first desired negative pressure.
In some embodiments, the method further comprises: deactivating the source of negative pressure if the negative pressure under the dressing has reached the second desired negative pressure or if the negative pressure under the dressing has not reached the second desired negative pressure upon expiration of a fourth time interval.
In some embodiments, the method further comprises: if the negative pressure under the dressing has not reached the second desired negative pressure upon expiration of the fourth time interval, activating the source of the negative pressure to generate the first desired negative pressure under the dressing upon expiration of the second time interval.
In some embodiments, the method further comprises: activating the source of the negative pressure to generate the first desired negative pressure under the dressing if the source of negative pressure has been activated to reach the second desired negative pressure for a second number of times less than a second threshold.
In some embodiments, the method further comprises:
In some embodiments, the method further comprises:
In some embodiments, the duty cycle comprises an amount, proportion, or percentage of time the source of negative pressure is active over a period of time.
In some embodiments, the method further comprises: calculating a number of duty cycles that exceed the first duty cycle threshold and deactivating the source of negative pressure when the number of duty cycles that exceed the first duty cycle threshold exceeds a second duty cycle threshold.
In some embodiments, the method further comprises: calculating a number of consecutive duty cycles that exceed the first duty cycle threshold.
In some embodiments, the second duty cycle threshold comprises 30 minutes.
In some embodiments, the method further comprises: upon expiration of the third time interval or upon receiving the signal from the switch to active the source of negative pressure, activating the source of negative pressure to generate the first desired negative pressure under the dressing.
In some embodiments, the source of negative pressure comprises a pump.
In some embodiments, the method further comprises sensing pressure under the dressing.
In some embodiments, the method further comprises: activating or deactivating the source of negative pressure by operating a valve.
Certain embodiments of the present invention provide the advantage that the raising of alarms due to transient leaks into a wound chamber can be avoided, while also reducing the potential for drawing contaminants into a wound site through a leak into the wound chamber.
Certain embodiments of the present invention provide the advantage of extending the useful life of a battery powered source of negative pressure used to provide a desired negative pressure to a wound site.
Embodiments of the present invention will now be described hereinafter, by way of example only, with reference to the accompanying drawings in which:
In the drawings like reference numerals refer to like parts.
Alternatively, a self contained wound dressing may be used in place of the drape, such a wound dressing absorbs wound exudate within the layers of the dressing removing the need for a separate fluid collection canister.
Further details regarding wound dressings that may be used in combination with the embodiments described herein are found in U.S. application Ser. No. 13/092,042, filed Apr. 21, 2011, the entirety of which is hereby incorporated by reference.
It is envisaged that the negative pressure range for the apparatus in certain embodiments of the present invention may be between about −50 mmHg and −200 mmHg (note that these pressures are relative to normal ambient atmospheric pressure thus, −200 mmHg would be about 560 mmHg in practical terms). Aptly, the pressure range may be between about −75 mmHg and −150 mmHg. Alternatively a pressure range of upto −75 mmHg, upto −80 mmHg or over −80 mmHg can be used. Also aptly a pressure range of below −75 mmHg could be used. Alternatively a pressure range of over −100 mmHg could be used or over −150 mmHg.
The pump 106 shown is a diaphragm pump which may be highly efficient and capable of providing the required negative pressure. It will be appreciated that other types of pump such as peristaltic pumps, or the like can be used. In some arrangements, the one-way check valve 104 may form part of the pump 106, and may not exist as a separate element of the apparatus.
While the apparatus has been described as being battery powered, it will be understood that the apparatus could alternatively draw electrical power from a mains power supply and the battery power cell removed. In some arrangements, the apparatus may be capable of being powered from either a mains power supply or a rechargeable battery that may be recharged from the mains power supply.
In operation, the inlet 102 is coupled to a wound chamber formed over a wound site 10, for example via the length of tube 16. The electric motor 108 drives the pump 106 under the control of the controller 112 to provide a negative pressure at the inlet 102. The negative pressure can then be communicated to the wound chamber in order to provide a desired negative pressure at the wound site. The check valve 104 maintains the level of negative pressure at the inlet 102 when the pump 106 is not active and helps avoid leaks.
Upon initially connecting the pressure control apparatus 100 to the wound chamber, the pressure at the wound site will be equal to atmospheric pressure, and an initial pump-down must be performed to establish the desired negative pressure at the wound site. This may require the pump 106 to be operated for an extended period of time until the desired negative pressure is achieved.
The pressure at the inlet 102 is indicative of the pressure experienced at the wound site, and this pressure is measured by the pressure sensor 116. The controller 112 receives the pressure value measured at the pressure sensor 116, and once the measured pressure reaches the desired negative pressure, the controller deactivates the pump 106. The controller 112 then continues to monitor the pressure at the pressure sensor.
If during the initial pump-down phase, the controller 112 determines that the desired negative pressure has not been achieved within a certain time (for example 10 minutes or 20 minutes or 30 minutes or 40 minutes or the like), then leaks may be present into the wound chamber, and this condition is signalled via the indicators 110 to show that the wound chamber has not been correctly sealed, or some other error or fault is present.
Once the desired negative pressure has been established, the controller 112 monitors the pressure at the inlet of the pressure control apparatus. From time to time, leaks of fluid may occur into the wound chamber, reducing the level of negative pressure experienced at the wound site, or in other words increasing the absolute pressure at the wound site. The pressure value measured at the pressure sensor 116 and provided to the controller 112 will therefore increase as fluid leaks into the wound chamber. When the measured negative pressure value drops below a certain defined pressure level, the controller 112 will reactivate the pump 106 in order to re-establish the desired negative pressure at the wound site. The desired negative pressure and the defined pressure level at which the controller reactivates the pump provide hysteresis limits between which the pressure should be maintained to apply topical negative pressure to the wound site.
However, if a leak forms that allows fluid, for example air, to leak into the wound chamber with a flow rate greater than the maximum pump capacity 106, it will not be possible for the pressure control apparatus 100 to maintain the desired negative pressure at the wound site. If the pressure control apparatus 100 continued to attempt to re-establish the desired negative pressure in the presence of such a leak, the battery power cell 114 would become depleted. Furthermore, continued operation of the pump in the presence of a large leak can draw contaminants into the wound site, and lead to excessive drying of the wound site which is undesirable. Therefore, the controller 112 is configured to deactivate the pump 106 if the desired negative pressure is not re-established after operation of the pump 106 for a predetermined period of time. For example sometime between around 30 minutes and 4 hours.
The formation of leaks into the wound chamber may occur due to a range of factors. One common cause of such leaks is movement of a patient being treated with the pressure control apparatus 100. For example, a leak may form when a patient moves from a lying to a sitting position, or during the normal range of movement when walking. Such leaks may be transient, and have been found to regularly reseal as the patient continues to move or returns to their previous position. Thus, there is a risk that the pump 106 may be deactivated due to the detection of a leak that subsequently reseals. However, once the leak reseals, operation of the pressure control apparatus would be able to re-establish the desired negative pressure within the wound chamber.
According to embodiments of the invention, the controller 112 is configured to deactivate the pump 106 after the pump has operated for a certain period of time without the desired level of negative pressure being reached in the wound chamber. That is a timeout event occurs. The controller then waits for a further period of time before a retry attempt is made to re-establish the desired negative pressure at the wound site using the pump 106. If the leak has resealed while the pump has been temporarily deactivated, the retry attempt to re-establish the desired negative pressure will be successful, and operation of the pressure control apparatus 100 can continue as normal. However, if the leak is still present a further timeout event will occur and the pump will be deactivated for the further period of time.
This cycle of deactivating the pump 106 and then attempting to re-establish the desired negative pressure may be repeated a number of times in order to provide an opportunity for any leaks to reseal. However, once a timeout event occurs the negative pressure at the wound site will start to degrade, and therefore there will be a break in the negative pressure wound therapy applied to the wound site. While a short break in therapy may not be a concern, an extended period in which the negative pressure is not applied should preferably be avoided. Furthermore, if a leak path into the wound chamber exists for an extended period of time, the potential for contaminants reaching the wound site increases. Thus, if a number, N, of unsuccessful attempts are made to re-establish the desired negative pressure it can be assumed that the leak is permanent, and not transient, and the controller 112 disables operation of the pressure control apparatus 100 and provides a signal via an audio and/or visual cue to a user that attention is required. This allows a patient or caregiver to arrange for any dressings or drapes to be changed to thereby reform the wound chamber and allow the negative pressure wound therapy to be continued. Aptly N is an integer between 1 and 5 inclusive.
Alternatively, the pump 106 and motor 108 may be omitted, and the negative pressure may be provided via an external source of negative pressure, such as by connection to a vacuum line or vacuum reservoir.
The operation of the pressure control apparatus 200 of
Unlike the pressure control apparatus of
Thus, the pressure control apparatus of
Controller 112, 212 may be implemented as a microcontroller, or an application specific integrated circuit, or the like, and may execute instructions to provide the above described control functions. For example, a suitable microcontroller would be one from the STM8L MCU family from ST Microelectronics, for example ST Microelectronics STM8L151G4U6, or one from the MC9S08QE4/8 series from Freescale, such as the Freescale MC9S08QE4CWJ.
The operation of the controller 112 may be described as a finite state machine. The operation of the controller is described below with reference to
Referring again to
Once the desired negative pressure has been successfully established, the controller transitions to the monitor pressure state 316. However, if after a predetermined period of time the desired pressure has not been established and the initial pump down state 312 is unable to establish the desired negative pressure (indicative of a leak), a timeout occurs. On the first timeout, the controller will transition to a wait state 314, in which the controller waits for a period of time before transitioning back to the initial pump down state 312. Further timeouts may occur from the initial pump-down state 312, and the controller maintains a count of the number of retry attempts made. Once the desired negative pressure has been established, the number of retry attempts may be reset.
If a timeout occurs and the number of retry cycles is greater than a predefined maximum number of retry attempts allowed, the controller transitions to a paused state 306. While in the paused state 306 the controller will transition from the paused state 306 to the initial pump down state 312 in response to a user input, or after a maximum pause time.
In the monitor pressure state 316, the controller monitors the pressure measured at the pressure sensor 116 and, if the pressure drops out of the desired pressure range, the controller transitions to a maintenance pump-down state 318. In the maintenance pump-down state 318, the suction pump is activated either for a predetermined period of time, for example between around 10 and 60 seconds, or until the desired negative pressure is re-established in the wound chamber, whichever occurs sooner.
It is noted that some hysteresis is built into the desired pressure range, such that the pressure value, a minimum desired negative pressure, that triggers a transition from the monitor pressure state 316 to the maintenance pump-down state 318 is lower than the desired negative pressure established in the wound chamber by operation of the pump during the maintenance pump-down state 318. For example, taking the operating pressure ranges discussed above, the desired negative pressure may be −150 mmHg and the minimum desired negative pressure may be −75 mmHg. Alternatively, the controller may act to maintain the pressure within a certain percentage range of the desired negative pressure, for example a 5% hysteresis may be used.
If the desired negative pressure is reached before the suction pump has been operating for the predetermined period of time, the controller transitions back to the monitor pressure state 316.
However, if the pump operates for the predetermined period of time without the desired negative pressure being re-established in the wound chamber, normally due to a leak into the wound chamber, the pressure control apparatus will signal the presence of a leak. If the pressure is within the hysteresis limits, i.e. between the minimum desired negative pressure and the desired negative pressure, this signifies the presence of a high leak, having a flow rate similar to the capacity of the pump. In this situation, the pump continues to operate until the desired negative pressure is re-established, or until the pressure at the wound site is no longer held within the hysteresis limits.
If in the presence of a large leak, the desired negative pressure is restored before a maximum maintenance time is reached, the controller will transition back to the monitor pressure state 316, but will signal the presence of a leak. However, if the suction pump is operated for more than the maximum maintenance time to restore the desired negative pressure, the controller will transition to the paused state 306, while signalling the presence of a leak.
If during the maintenance pump-down state 318, the pressure in the wound chamber is not maintained within the hysteresis limits, a catastrophic leak has occurred, and the controller transitions to the wait state 314.
In some embodiments, if after a predetermined period of time, the desired pressure has not been established and the maintenance pump down state 318 is unable to establish the desired negative pressure before the maximum maintenance time is reached, a timeout occurs. On the first timeout, the controller will transition to the wait state 314, in which the controller waits for a period of time before transitioning back to the initial pump down state 312. Further timeouts may occur from the maintenance pump-down state 318, and the controller maintains a count of the number of retry attempts made. Once the desired negative pressure has been established in the maintenance pump down state 318, the number of retry attempts may be reset. If a timeout occurs and the number of retry attempts is greater than a predefined maximum number of retry attempts allowed, the controller transitions to the paused state 306, as described above.
Thus, if the leak is such that it is over a prescribed limit and the pump duty cycle (DC) as defined, in some embodiments, as pump on time divided by pump off time is over a predetermined limit then the pump shall continue to operate within the hysteresis limits for a particular time duration. For example, around 30 minutes as shown in
At any time while in the operational state 308, the controller may be placed in the pause state 306 in response to a user input. Once the battery voltage reaches a low voltage cut off level or the lifetime of the pressure control apparatus has been reached, the controller de-activates the pressure control apparatus and an End of Life state is reached.
The controller 212 described with respect of the pressure control apparatus 200 of
Alternatively, the POST state 302 may be omitted.
The pressure control apparatus may be configured to be re-useable and be provided with a switch to allow the apparatus to be turned on and off as required. Such a re-usable apparatus may include rechargeable power cells, and may provide a low power indication in order to allow the power cells to be replaced/recharged.
In a disposable single use pressure control apparatus, activation may be provided by pulling an activation strip and it may not be possible to deactivate the apparatus once activated until the apparatus is to be discarded.
Throughout the description and claims of this specification, the words “comprise” and “contain” and variations of the words, for example “comprising” and “comprises”, means “including but not limited to”, and is not intended to (and does not) exclude other moieties, additives, components, integers or steps.
Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith.
Number | Date | Country | Kind |
---|---|---|---|
1015656 | Sep 2010 | GB | national |
This application is a continuation of U.S. patent application Ser. No. 17/339,464, filed Jun. 4, 2021, which is a continuation of U.S. patent application Ser. No. 16/141,701, filed on Sep. 25, 2018 and issued as U.S. Pat. No. 11,027,051, which is a continuation of U.S. patent application Ser. No. 15/941,908, filed on Mar. 30, 2018 and issued as U.S. Pat. No. 10,105,473, which is a continuation of U.S. patent application Ser. No. 14/972,734, filed on Dec. 17, 2015 and issued as U.S. Pat. No. 10,058,644, which is a continuation of U.S. patent application Ser. No. 14/256,658, filed on Apr. 18, 2014 and issued as U.S. Pat. No. 9,220,823, which is a continuation of U.S. patent application Ser. No. 13/824,982, filed on Jun. 26, 2013 and issued as U.S. Pat. No. 8,734,425, which is a U.S. National Phase application under 35 U.S.C. § 371 of International Application PCT/GB2011/051745, filed Sep. 16, 2011, which claims priority to Great Britain Patent Application No. 1015656.0, filed Sep. 20, 2010. The disclosures of these prior applications are incorporated by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
3572340 | Lloyd et al. | Mar 1971 | A |
3787882 | Fillmore et al. | Jan 1974 | A |
3972328 | Chen | Aug 1976 | A |
4015912 | Kofink | Apr 1977 | A |
4062012 | Colbert et al. | Dec 1977 | A |
4599052 | Langen et al. | Jul 1986 | A |
4643641 | Clausen et al. | Feb 1987 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4969880 | Zamierowski | Nov 1990 | A |
5127388 | Cicalese et al. | Jul 1992 | A |
5173033 | Adahan | Dec 1992 | A |
5222714 | Morinigo et al. | Jun 1993 | A |
5238732 | Krishnan | Aug 1993 | A |
5291822 | Alsobrooks et al. | Mar 1994 | A |
5349896 | Delaney, III et al. | Sep 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5360445 | Goldowsky | Nov 1994 | A |
5391179 | Mezzoli | Feb 1995 | A |
5417743 | Dauber | May 1995 | A |
5449003 | Sugimura | Sep 1995 | A |
5449347 | Preen et al. | Sep 1995 | A |
5449584 | Banba et al. | Sep 1995 | A |
5466229 | Elson et al. | Nov 1995 | A |
5492313 | Pan et al. | Feb 1996 | A |
5549584 | Gross | Aug 1996 | A |
5616121 | McKay | Apr 1997 | A |
5634391 | Eady | Jun 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5676525 | Berner et al. | Oct 1997 | A |
5685214 | Neff et al. | Nov 1997 | A |
5687633 | Eady | Nov 1997 | A |
5693013 | Geuder | Dec 1997 | A |
5730587 | Snyder et al. | Mar 1998 | A |
5743170 | Pascual et al. | Apr 1998 | A |
5759570 | Arnold | Jun 1998 | A |
5769608 | Seale | Jun 1998 | A |
5785508 | Bolt | Jul 1998 | A |
5863184 | Juterbock et al. | Jan 1999 | A |
5897296 | Yamamoto et al. | Apr 1999 | A |
5950523 | Reynolds | Sep 1999 | A |
6056519 | Morita et al. | May 2000 | A |
6068588 | Goldowsky | May 2000 | A |
6071267 | Zamierowski | Jun 2000 | A |
6080685 | Eady | Jun 2000 | A |
6102680 | Fraser et al. | Aug 2000 | A |
6138550 | Fingar, Jr. et al. | Oct 2000 | A |
6142982 | Hunt et al. | Nov 2000 | A |
6145430 | Able et al. | Nov 2000 | A |
6158327 | Huss | Dec 2000 | A |
6162194 | Shipp | Dec 2000 | A |
6174136 | Kilayko et al. | Jan 2001 | B1 |
6227825 | Vay | May 2001 | B1 |
6230609 | Bender et al. | May 2001 | B1 |
6231310 | Tojo et al. | May 2001 | B1 |
6249198 | Clark et al. | Jun 2001 | B1 |
6323568 | Zabar | Nov 2001 | B1 |
6327960 | Heimueller et al. | Dec 2001 | B1 |
6343539 | Du | Feb 2002 | B1 |
6413057 | Hong et al. | Jul 2002 | B1 |
6514047 | Burr et al. | Feb 2003 | B2 |
6540490 | Lilie | Apr 2003 | B1 |
6589028 | Eckerbom et al. | Jul 2003 | B1 |
6604908 | Bryant et al. | Aug 2003 | B1 |
6618221 | Gillis et al. | Sep 2003 | B2 |
6623255 | Joong et al. | Sep 2003 | B2 |
6626891 | Ohmstede | Sep 2003 | B2 |
6638035 | Puff | Oct 2003 | B1 |
6652252 | Zabar | Nov 2003 | B2 |
6655257 | Meyer | Dec 2003 | B1 |
6673036 | Britto | Jan 2004 | B1 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6755807 | Risk, Jr. et al. | Jun 2004 | B2 |
6756903 | Omry et al. | Jun 2004 | B2 |
6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
6815846 | Godkin | Nov 2004 | B2 |
6823905 | Smith et al. | Nov 2004 | B1 |
6877419 | Ohrle et al. | Apr 2005 | B2 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7022113 | Lockwood et al. | Apr 2006 | B2 |
7041057 | Faupel et al. | May 2006 | B1 |
7108683 | Zamierowski | Sep 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7151348 | Ueda et al. | Dec 2006 | B1 |
7361184 | Joshi | Apr 2008 | B2 |
7363850 | Becker | Apr 2008 | B2 |
7374409 | Kawamura | May 2008 | B2 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7401703 | McMichael et al. | Jul 2008 | B2 |
7447327 | Kitamura et al. | Nov 2008 | B2 |
7524315 | Blott et al. | Apr 2009 | B2 |
7534927 | Lockwood et al. | May 2009 | B2 |
7550034 | Janse Van Rensburg et al. | Jun 2009 | B2 |
7553306 | Hunt et al. | Jun 2009 | B1 |
7569742 | Haggstrom et al. | Aug 2009 | B2 |
7615036 | Joshi et al. | Nov 2009 | B2 |
7625362 | Boehringer et al. | Dec 2009 | B2 |
7670323 | Hunt et al. | Mar 2010 | B2 |
7699823 | Haggstrom et al. | Apr 2010 | B2 |
7700819 | Ambrosio et al. | Apr 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7722582 | Lina et al. | May 2010 | B2 |
7758555 | Kelch et al. | Jul 2010 | B2 |
7759537 | Bishop et al. | Jul 2010 | B2 |
7759539 | Shaw et al. | Jul 2010 | B2 |
7775998 | Riesinger | Aug 2010 | B2 |
7779625 | Joshi et al. | Aug 2010 | B2 |
7785247 | Tatum et al. | Aug 2010 | B2 |
7811269 | Boynton et al. | Oct 2010 | B2 |
7838717 | Haggstrom et al. | Nov 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
7909805 | Weston | Mar 2011 | B2 |
7910791 | Coffey | Mar 2011 | B2 |
7922703 | Riesinger | Apr 2011 | B2 |
7927319 | Lawhorn | Apr 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
8007257 | Heaton et al. | Aug 2011 | B2 |
8025052 | Matthews et al. | Sep 2011 | B2 |
8034037 | Adams et al. | Oct 2011 | B2 |
8048046 | Hudspeth et al. | Nov 2011 | B2 |
8061360 | Locke et al. | Nov 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8062273 | Weston | Nov 2011 | B2 |
8062331 | Zamierowski | Nov 2011 | B2 |
8080702 | Blott et al. | Dec 2011 | B2 |
8097272 | Addison | Jan 2012 | B2 |
8105295 | Blott et al. | Jan 2012 | B2 |
8118794 | Weston | Feb 2012 | B2 |
8152785 | Vitaris | Apr 2012 | B2 |
8162907 | Heagle | Apr 2012 | B2 |
8167869 | Wudyka | May 2012 | B2 |
8186978 | Tinholt et al. | May 2012 | B2 |
8188331 | Barta et al. | May 2012 | B2 |
8207392 | Haggstrom et al. | Jun 2012 | B2 |
8215929 | Shen et al. | Jul 2012 | B2 |
8235972 | Adahan | Aug 2012 | B2 |
8241015 | Lillie et al. | Aug 2012 | B2 |
8241018 | Harr | Aug 2012 | B2 |
8241261 | Randolph et al. | Aug 2012 | B2 |
8257327 | Blott et al. | Sep 2012 | B2 |
8257328 | Augustine et al. | Sep 2012 | B2 |
8267918 | Johnson et al. | Sep 2012 | B2 |
8282611 | Weston | Oct 2012 | B2 |
8294586 | Pidgeon et al. | Oct 2012 | B2 |
8303552 | Weston | Nov 2012 | B2 |
8317774 | Adahan | Nov 2012 | B2 |
8323264 | Weston et al. | Dec 2012 | B2 |
8350116 | Lockwood et al. | Jan 2013 | B2 |
8363881 | Godkin | Jan 2013 | B2 |
8366690 | Locke et al. | Feb 2013 | B2 |
8366692 | Weston et al. | Feb 2013 | B2 |
8372049 | Jaeb et al. | Feb 2013 | B2 |
8372050 | Jaeb et al. | Feb 2013 | B2 |
8398614 | Blott et al. | Mar 2013 | B2 |
D679819 | Peron | Apr 2013 | S |
D679820 | Peron | Apr 2013 | S |
8409157 | Haggstrom et al. | Apr 2013 | B2 |
8409159 | Hu et al. | Apr 2013 | B2 |
8409160 | Locke et al. | Apr 2013 | B2 |
8409170 | Locke | Apr 2013 | B2 |
8414519 | Hudspeth et al. | Apr 2013 | B2 |
8425478 | Olson | Apr 2013 | B2 |
8429778 | Receveur et al. | Apr 2013 | B2 |
8444612 | Patel et al. | May 2013 | B2 |
8449267 | Pascual et al. | May 2013 | B2 |
8449509 | Weston | May 2013 | B2 |
8460255 | Joshi et al. | Jun 2013 | B2 |
8500718 | Locke et al. | Aug 2013 | B2 |
8513481 | Gergely et al. | Aug 2013 | B2 |
8540688 | Eckstein et al. | Sep 2013 | B2 |
8545464 | Weston | Oct 2013 | B2 |
8545466 | Andresen et al. | Oct 2013 | B2 |
8569566 | Blott et al. | Oct 2013 | B2 |
8579872 | Coulthard et al. | Nov 2013 | B2 |
8617129 | Hartwell | Dec 2013 | B2 |
8622981 | Hartwell et al. | Jan 2014 | B2 |
8628505 | Weston | Jan 2014 | B2 |
8641691 | Fink et al. | Feb 2014 | B2 |
8646479 | Jaeb et al. | Feb 2014 | B2 |
8663198 | Buan et al. | Mar 2014 | B2 |
8708984 | Robinson et al. | Apr 2014 | B2 |
8715256 | Greener | May 2014 | B2 |
8734131 | McCrone et al. | May 2014 | B2 |
8734425 | Nicolini | May 2014 | B2 |
8764732 | Hartwell | Jul 2014 | B2 |
8795243 | Weston | Aug 2014 | B2 |
8808274 | Hartwell | Aug 2014 | B2 |
8814841 | Hartwell | Aug 2014 | B2 |
8827983 | Braga et al. | Sep 2014 | B2 |
8829263 | Haggstrom et al. | Sep 2014 | B2 |
8834451 | Blott et al. | Sep 2014 | B2 |
8843327 | Vernon-Harcourt et al. | Sep 2014 | B2 |
8845603 | Middleton et al. | Sep 2014 | B2 |
8905985 | Allen et al. | Dec 2014 | B2 |
8926592 | Blott et al. | Jan 2015 | B2 |
8945074 | Buan et al. | Feb 2015 | B2 |
8951235 | Allen et al. | Feb 2015 | B2 |
8956336 | Haggstrom et al. | Feb 2015 | B2 |
8974429 | Gordon et al. | Mar 2015 | B2 |
9012714 | Fleischmann | Apr 2015 | B2 |
9061095 | Adie et al. | Jun 2015 | B2 |
9067003 | Buan et al. | Jun 2015 | B2 |
9084845 | Adie et al. | Jul 2015 | B2 |
9127665 | Locke et al. | Sep 2015 | B2 |
9180231 | Greener | Nov 2015 | B2 |
9199011 | Locke et al. | Dec 2015 | B2 |
9199012 | Vitaris et al. | Dec 2015 | B2 |
9220822 | Hartwell | Dec 2015 | B2 |
9220823 | Nicolini | Dec 2015 | B2 |
9314557 | Ricci et al. | Apr 2016 | B2 |
9408954 | Gordon et al. | Aug 2016 | B2 |
9421309 | Robinson et al. | Aug 2016 | B2 |
9446178 | Blott et al. | Sep 2016 | B2 |
9506463 | Locke et al. | Nov 2016 | B2 |
9518575 | Felber | Dec 2016 | B2 |
9629986 | Patel et al. | Apr 2017 | B2 |
9681993 | Wu et al. | Jun 2017 | B2 |
9737649 | Begin et al. | Aug 2017 | B2 |
9877872 | Mumby et al. | Jan 2018 | B2 |
9956325 | Malhi | May 2018 | B2 |
10058644 | Nicolini | Aug 2018 | B2 |
10105473 | Nicolini | Oct 2018 | B2 |
10143783 | Adie et al. | Dec 2018 | B2 |
10307517 | Allen et al. | Jun 2019 | B2 |
20010001278 | Drevet | May 2001 | A1 |
20010033795 | Humpheries | Oct 2001 | A1 |
20010043870 | Song | Nov 2001 | A1 |
20020026946 | McKay | Mar 2002 | A1 |
20020122732 | Oh et al. | Sep 2002 | A1 |
20020164255 | Burr et al. | Nov 2002 | A1 |
20030035743 | Lee et al. | Feb 2003 | A1 |
20030095879 | Oh et al. | May 2003 | A1 |
20030099558 | Chang | May 2003 | A1 |
20030108430 | Yoshida et al. | Jun 2003 | A1 |
20030110939 | Able et al. | Jun 2003 | A1 |
20030133812 | Puff et al. | Jul 2003 | A1 |
20030161735 | Kim et al. | Aug 2003 | A1 |
20030162071 | Yasuda | Aug 2003 | A1 |
20030175125 | Kwon et al. | Sep 2003 | A1 |
20030175135 | Heo et al. | Sep 2003 | A1 |
20030230191 | Ohrle et al. | Dec 2003 | A1 |
20040005222 | Yoshida et al. | Jan 2004 | A1 |
20040021123 | Howell et al. | Feb 2004 | A1 |
20040064132 | Boehringer et al. | Apr 2004 | A1 |
20040066097 | Kobayashi et al. | Apr 2004 | A1 |
20040071568 | Hyeon | Apr 2004 | A1 |
20040071572 | Greter | Apr 2004 | A1 |
20040115076 | Lilie et al. | Jun 2004 | A1 |
20040118460 | Stinson | Jun 2004 | A1 |
20040126250 | Tsuchiya et al. | Jul 2004 | A1 |
20040155741 | Godin | Aug 2004 | A1 |
20040156730 | Lilie et al. | Aug 2004 | A1 |
20040163713 | Schulze et al. | Aug 2004 | A1 |
20040182237 | Headley et al. | Sep 2004 | A1 |
20040189103 | Duncan et al. | Sep 2004 | A1 |
20040219059 | Barringer et al. | Nov 2004 | A1 |
20050031470 | Lee | Feb 2005 | A1 |
20050098031 | Yoon et al. | May 2005 | A1 |
20050100450 | Bryant et al. | May 2005 | A1 |
20050110190 | Giardini et al. | May 2005 | A1 |
20050111987 | Yoo et al. | May 2005 | A1 |
20050123422 | Lilie | Jun 2005 | A1 |
20050124966 | Karpowicz et al. | Jun 2005 | A1 |
20050129540 | Puff | Jun 2005 | A1 |
20050135946 | Kang et al. | Jun 2005 | A1 |
20050142007 | Lee et al. | Jun 2005 | A1 |
20050142008 | Jung et al. | Jun 2005 | A1 |
20050155657 | Kach et al. | Jul 2005 | A1 |
20050163635 | Berwanger et al. | Jul 2005 | A1 |
20050209560 | Boukhny et al. | Sep 2005 | A1 |
20050251117 | Anderson et al. | Nov 2005 | A1 |
20050267402 | Stewart et al. | Dec 2005 | A1 |
20050271526 | Chang et al. | Dec 2005 | A1 |
20050272142 | Horita | Dec 2005 | A1 |
20050276706 | Radue | Dec 2005 | A1 |
20060009744 | Erdman et al. | Jan 2006 | A1 |
20060017332 | Kang et al. | Jan 2006 | A1 |
20060018771 | Song et al. | Jan 2006 | A1 |
20060019144 | Hidaka et al. | Jan 2006 | A1 |
20060024181 | Kim | Feb 2006 | A1 |
20060029675 | Ginther | Feb 2006 | A1 |
20060039806 | Becker | Feb 2006 | A1 |
20060056979 | Yoo et al. | Mar 2006 | A1 |
20060056980 | Yoo et al. | Mar 2006 | A1 |
20060057000 | Hyeon | Mar 2006 | A1 |
20060061024 | Jung et al. | Mar 2006 | A1 |
20060073036 | Pascual et al. | Apr 2006 | A1 |
20060083623 | Higgins et al. | Apr 2006 | A1 |
20060110259 | Puff et al. | May 2006 | A1 |
20060118190 | Takehana et al. | Jun 2006 | A1 |
20060122558 | Sherman et al. | Jun 2006 | A1 |
20060191575 | Naesje | Aug 2006 | A1 |
20060192259 | Silverbrook | Aug 2006 | A1 |
20060210411 | Hyeon | Sep 2006 | A1 |
20060216165 | Lee | Sep 2006 | A1 |
20060222532 | Lee et al. | Oct 2006 | A1 |
20060228224 | Hong et al. | Oct 2006 | A1 |
20060245947 | Seto et al. | Nov 2006 | A1 |
20060251523 | Lee et al. | Nov 2006 | A1 |
20060271020 | Huang et al. | Nov 2006 | A1 |
20060282174 | Haines | Dec 2006 | A1 |
20060282175 | Haines et al. | Dec 2006 | A1 |
20060287632 | Sarangapani | Dec 2006 | A1 |
20070014837 | Johnson et al. | Jan 2007 | A1 |
20070016152 | Karpowicz et al. | Jan 2007 | A1 |
20070032741 | Hibner et al. | Feb 2007 | A1 |
20070032762 | Vogel | Feb 2007 | A1 |
20070032763 | Vogel | Feb 2007 | A1 |
20070040454 | Freudenberger et al. | Feb 2007 | A1 |
20070041856 | Hansen et al. | Feb 2007 | A1 |
20070052144 | Knirck et al. | Mar 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070078444 | Larsson | Apr 2007 | A1 |
20070091614 | Kaisser et al. | Apr 2007 | A1 |
20070179460 | Adahan | Aug 2007 | A1 |
20070196214 | Bocchiola | Aug 2007 | A1 |
20070219532 | Karpowicz et al. | Sep 2007 | A1 |
20070225663 | Watt et al. | Sep 2007 | A1 |
20070256428 | Unger et al. | Nov 2007 | A1 |
20070260226 | Jaeb et al. | Nov 2007 | A1 |
20070282283 | Kaern et al. | Dec 2007 | A1 |
20070292286 | Hell et al. | Dec 2007 | A1 |
20070295201 | Dadd | Dec 2007 | A1 |
20080008607 | Schade et al. | Jan 2008 | A1 |
20080015526 | Reiner et al. | Jan 2008 | A1 |
20080020178 | Ohrle et al. | Jan 2008 | A1 |
20080051708 | Kumar et al. | Feb 2008 | A1 |
20080082040 | Kubler et al. | Apr 2008 | A1 |
20080089796 | Schade et al. | Apr 2008 | A1 |
20080094753 | Brodkin et al. | Apr 2008 | A1 |
20080110336 | Cresswell et al. | May 2008 | A1 |
20080125697 | Gao | May 2008 | A1 |
20080125698 | Gerg et al. | May 2008 | A1 |
20080191399 | Chang | Aug 2008 | A1 |
20080211435 | Imagawa | Sep 2008 | A1 |
20080240942 | Heinrich et al. | Oct 2008 | A1 |
20080260551 | Simmons | Oct 2008 | A1 |
20080267797 | Hell et al. | Oct 2008 | A1 |
20080281281 | Meyer et al. | Nov 2008 | A1 |
20080306456 | Riesinger | Dec 2008 | A1 |
20080310980 | Ramsdorf et al. | Dec 2008 | A1 |
20090008306 | Cicchello | Jan 2009 | A1 |
20090012441 | Mulligan | Jan 2009 | A1 |
20090028733 | Duwel | Jan 2009 | A1 |
20090030383 | Larsen et al. | Jan 2009 | A1 |
20090030402 | Adahan | Jan 2009 | A1 |
20090053081 | Griffiths | Feb 2009 | A1 |
20090054855 | Blott et al. | Feb 2009 | A1 |
20090060750 | Chen et al. | Mar 2009 | A1 |
20090071551 | Chalich | Mar 2009 | A1 |
20090081049 | Tian et al. | Mar 2009 | A1 |
20090087323 | Blakey et al. | Apr 2009 | A1 |
20090114293 | Kanai et al. | May 2009 | A1 |
20090123513 | Greener | May 2009 | A1 |
20090125004 | Shen et al. | May 2009 | A1 |
20090129955 | Schubert | May 2009 | A1 |
20090129986 | Wimberger-Friedl et al. | May 2009 | A1 |
20090148320 | Lucas | Jun 2009 | A1 |
20090149821 | Scherson et al. | Jun 2009 | A1 |
20090166411 | Kramer et al. | Jul 2009 | A1 |
20090169402 | Stenberg | Jul 2009 | A1 |
20090177051 | Arons et al. | Jul 2009 | A1 |
20090206778 | Roh et al. | Aug 2009 | A1 |
20090234306 | Vitaris | Sep 2009 | A1 |
20090270833 | DeBelser et al. | Oct 2009 | A1 |
20090299251 | Buan | Dec 2009 | A1 |
20090299306 | Buan | Dec 2009 | A1 |
20090304534 | Richter | Dec 2009 | A1 |
20090312723 | Blott et al. | Dec 2009 | A1 |
20090312725 | Braga | Dec 2009 | A1 |
20090315684 | Sacco et al. | Dec 2009 | A1 |
20100036367 | Krohn | Feb 2010 | A1 |
20100042059 | Pratt et al. | Feb 2010 | A1 |
20100068820 | Meathrel et al. | Mar 2010 | A1 |
20100098566 | Kang | Apr 2010 | A1 |
20100125258 | Coulthard et al. | May 2010 | A1 |
20100126484 | Skell et al. | May 2010 | A1 |
20100145289 | Lina et al. | Jun 2010 | A1 |
20100160881 | Lin et al. | Jun 2010 | A1 |
20100191178 | Ross et al. | Jul 2010 | A1 |
20100211030 | Turner et al. | Aug 2010 | A1 |
20100244780 | Turner et al. | Sep 2010 | A1 |
20100249733 | Blott et al. | Sep 2010 | A9 |
20100265649 | Singh et al. | Oct 2010 | A1 |
20100268179 | Kelch et al. | Oct 2010 | A1 |
20100280435 | Raney et al. | Nov 2010 | A1 |
20100318071 | Wudyka | Dec 2010 | A1 |
20100320659 | Chen et al. | Dec 2010 | A1 |
20110000069 | Ramsdorf et al. | Jan 2011 | A1 |
20110004172 | Eckstein et al. | Jan 2011 | A1 |
20110015587 | Tumey et al. | Jan 2011 | A1 |
20110020588 | Shimizu et al. | Jan 2011 | A1 |
20110028921 | Hartwell et al. | Feb 2011 | A1 |
20110038741 | Lissner et al. | Feb 2011 | A1 |
20110043055 | Chiang | Feb 2011 | A1 |
20110054423 | Blott et al. | Mar 2011 | A1 |
20110071415 | Karwoski et al. | Mar 2011 | A1 |
20110077605 | Karpowicz | Mar 2011 | A1 |
20110081267 | McCrone et al. | Apr 2011 | A1 |
20110098600 | Matsumura et al. | Apr 2011 | A1 |
20110103984 | Santa | May 2011 | A1 |
20110118683 | Weston | May 2011 | A1 |
20110130712 | Topaz | Jun 2011 | A1 |
20110144599 | Croizat et al. | Jun 2011 | A1 |
20110169348 | Park | Jul 2011 | A1 |
20110171044 | Flanigan | Jul 2011 | A1 |
20110176945 | Drevet | Jul 2011 | A1 |
20110176946 | Drevet | Jul 2011 | A1 |
20110184341 | Baker et al. | Jul 2011 | A1 |
20110186765 | Jaeb et al. | Aug 2011 | A1 |
20110196321 | Wudyka | Aug 2011 | A1 |
20110202220 | Seta et al. | Aug 2011 | A1 |
20110205646 | Sato et al. | Aug 2011 | A1 |
20110205647 | Osaka et al. | Aug 2011 | A1 |
20110224631 | Simmons et al. | Sep 2011 | A1 |
20110229352 | Timmer | Sep 2011 | A1 |
20110236265 | Hasui et al. | Sep 2011 | A1 |
20110236277 | Lee et al. | Sep 2011 | A1 |
20110245682 | Robinson et al. | Oct 2011 | A1 |
20110251569 | Turner et al. | Oct 2011 | A1 |
20110257572 | Locke et al. | Oct 2011 | A1 |
20110311379 | Hale et al. | Dec 2011 | A1 |
20120000208 | Hon et al. | Jan 2012 | A1 |
20120008817 | Grinker et al. | Jan 2012 | A1 |
20120034109 | Tout et al. | Feb 2012 | A1 |
20120046625 | Johannison | Feb 2012 | A1 |
20120053543 | Miau et al. | Mar 2012 | A1 |
20120160091 | Dadd et al. | Jun 2012 | A1 |
20120165764 | Allen et al. | Jun 2012 | A1 |
20120177513 | Lilie et al. | Jul 2012 | A1 |
20120184930 | Johannison | Jul 2012 | A1 |
20120220960 | Ruland | Aug 2012 | A1 |
20120232502 | Lowing | Sep 2012 | A1 |
20120251359 | Neelakantan et al. | Oct 2012 | A1 |
20120259299 | Ryu et al. | Oct 2012 | A1 |
20120271256 | Locke et al. | Oct 2012 | A1 |
20120289895 | Tsoukalis | Nov 2012 | A1 |
20120289913 | Eckstein et al. | Nov 2012 | A1 |
20120301341 | Ota et al. | Nov 2012 | A1 |
20130017110 | Villagomez et al. | Jan 2013 | A1 |
20130042753 | Becker et al. | Feb 2013 | A1 |
20130066285 | Locke et al. | Mar 2013 | A1 |
20130085462 | Nip et al. | Apr 2013 | A1 |
20130090613 | Kelch et al. | Apr 2013 | A1 |
20130118622 | Patzold et al. | May 2013 | A1 |
20130123755 | Locke et al. | May 2013 | A1 |
20130138054 | Fleischmann | May 2013 | A1 |
20130144235 | Augustine et al. | Jun 2013 | A1 |
20130150814 | Buan | Jun 2013 | A1 |
20130165878 | Heagle | Jun 2013 | A1 |
20130267917 | Pan et al. | Oct 2013 | A1 |
20130274688 | Weston | Oct 2013 | A1 |
20130280113 | Miranda et al. | Oct 2013 | A1 |
20130296762 | Toth | Nov 2013 | A1 |
20130340870 | Ito et al. | Dec 2013 | A1 |
20140100516 | Hunt et al. | Apr 2014 | A1 |
20140114268 | Auguste et al. | Apr 2014 | A1 |
20140127148 | Derain | May 2014 | A1 |
20140163490 | Locke et al. | Jun 2014 | A1 |
20140194835 | Ehlert | Jul 2014 | A1 |
20140228791 | Hartwell | Aug 2014 | A1 |
20140276487 | Locke et al. | Sep 2014 | A1 |
20140316359 | Collinson et al. | Oct 2014 | A1 |
20150032035 | Banwell et al. | Jan 2015 | A1 |
20150051560 | Askem | Feb 2015 | A1 |
20150073363 | Kelch et al. | Mar 2015 | A1 |
20150217032 | Allen et al. | Aug 2015 | A1 |
20150335798 | De Samber et al. | Nov 2015 | A1 |
20160166741 | Nicolini | Jun 2016 | A1 |
20160319957 | Jaeb et al. | Nov 2016 | A1 |
20180221547 | Nicolini | Aug 2018 | A1 |
20190167863 | Adie et al. | Jun 2019 | A1 |
20190307934 | Allen et al. | Oct 2019 | A1 |
20200171217 | Braga et al. | Jun 2020 | A9 |
Number | Date | Country |
---|---|---|
101378795 | Mar 2009 | CN |
101385887 | Mar 2009 | CN |
101516431 | Aug 2009 | CN |
101616700 | Dec 2009 | CN |
101676563 | Mar 2010 | CN |
201953601 | Aug 2011 | CN |
103221077 | Jul 2013 | CN |
102005007016 | Aug 2006 | DE |
0208395 | Jan 1987 | EP |
0411564 | Feb 1991 | EP |
0578999 | Jan 1994 | EP |
0604953 | Jul 1994 | EP |
0759521 | Feb 1997 | EP |
0775825 | May 1997 | EP |
0793019 | Sep 1997 | EP |
0809028 | Nov 1997 | EP |
0898076 | Feb 1999 | EP |
0909895 | Apr 1999 | EP |
1114933 | Jul 2001 | EP |
1153218 | Nov 2001 | EP |
0708620 | May 2003 | EP |
0993317 | Sep 2003 | EP |
1406020 | Apr 2004 | EP |
1430588 | Jun 2004 | EP |
1449971 | Aug 2004 | EP |
1554737 | Jul 2005 | EP |
1556942 | Jul 2005 | EP |
1469580 | Dec 2005 | EP |
1757809 | Feb 2007 | EP |
1850005 | Oct 2007 | EP |
1476217 | Mar 2008 | EP |
1460270 | Jun 2008 | EP |
1791579 | Jul 2009 | EP |
2145636 | Jan 2010 | EP |
2161448 | Mar 2010 | EP |
1932481 | Jun 2010 | EP |
2216573 | Aug 2010 | EP |
2253353 | Nov 2010 | EP |
2302127 | Mar 2011 | EP |
1956242 | Apr 2011 | EP |
2366721 | Sep 2011 | EP |
2462908 | Jun 2012 | EP |
2544642 | Jan 2015 | EP |
2648668 | Jan 2015 | EP |
2830555 | Feb 2015 | EP |
2836711 | Feb 2015 | EP |
2254612 | Oct 2019 | EP |
1163907 | Oct 1958 | FR |
1039145 | Aug 1966 | GB |
1220857 | Jan 1971 | GB |
2235877 | Mar 1991 | GB |
2273133 | Jun 1994 | GB |
2306580 | May 1997 | GB |
2342584 | Apr 2000 | GB |
2418738 | Apr 2006 | GB |
2433298 | Jun 2007 | GB |
2000105011 | Apr 2000 | JP |
2000220570 | Aug 2000 | JP |
2000300662 | Oct 2000 | JP |
2001241382 | Sep 2001 | JP |
2001286807 | Oct 2001 | JP |
2006233925 | Sep 2006 | JP |
2008183244 | Aug 2008 | JP |
2008194294 | Aug 2008 | JP |
2010185458 | Aug 2010 | JP |
2013514871 | May 2013 | JP |
WO-8707683 | Dec 1987 | WO |
WO-9421312 | Sep 1994 | WO |
WO-9819068 | May 1998 | WO |
WO-0000743 | Jan 2000 | WO |
WO-0007653 | Feb 2000 | WO |
WO-0021586 | Apr 2000 | WO |
WO-0022298 | Apr 2000 | WO |
WO-0049968 | Aug 2000 | WO |
WO-0056378 | Sep 2000 | WO |
WO-0061206 | Oct 2000 | WO |
WO-0079154 | Dec 2000 | WO |
WO-0116488 | Mar 2001 | WO |
WO-0179693 | Oct 2001 | WO |
WO-02087058 | Oct 2002 | WO |
WO-02090772 | Nov 2002 | WO |
WO-03057307 | Jul 2003 | WO |
WO-03085810 | Oct 2003 | WO |
WO-03099356 | Dec 2003 | WO |
WO-03101508 | Dec 2003 | WO |
WO-2004007960 | Jan 2004 | WO |
WO-2004081421 | Sep 2004 | WO |
WO-2005001287 | Jan 2005 | WO |
WO-2005009488 | Feb 2005 | WO |
WO-2005123170 | Dec 2005 | WO |
WO-2006046060 | May 2006 | WO |
WO-2006052839 | May 2006 | WO |
WO-2006058801 | Jun 2006 | WO |
WO-2006059098 | Jun 2006 | WO |
WO-2006062276 | Jun 2006 | WO |
WO-2006069875 | Jul 2006 | WO |
WO-2006069884 | Jul 2006 | WO |
WO-2006069885 | Jul 2006 | WO |
WO-2006092333 | Sep 2006 | WO |
WO-2006111775 | Oct 2006 | WO |
WO-2006117207 | Nov 2006 | WO |
WO-2006122268 | Nov 2006 | WO |
WO-2007019038 | Feb 2007 | WO |
WO-2007049876 | May 2007 | WO |
WO-2007055642 | May 2007 | WO |
WO-2007067359 | Jun 2007 | WO |
WO-2007087810 | Aug 2007 | WO |
WO-2007087811 | Aug 2007 | WO |
WO-2007092397 | Aug 2007 | WO |
WO-2007113597 | Oct 2007 | WO |
WO-2008013896 | Jan 2008 | WO |
WO-2008027449 | Mar 2008 | WO |
WO-2008031418 | Mar 2008 | WO |
WO-2008039223 | Apr 2008 | WO |
WO-2008039314 | Apr 2008 | WO |
WO-2008048481 | Apr 2008 | WO |
WO-2008049029 | Apr 2008 | WO |
WO-2008100440 | Aug 2008 | WO |
WO-2008110022 | Sep 2008 | WO |
WO-2008135997 | Nov 2008 | WO |
WO-2008154158 | Dec 2008 | WO |
WO-2009004367 | Jan 2009 | WO |
WO-2009019415 | Feb 2009 | WO |
WO-2009047524 | Apr 2009 | WO |
WO-2009066104 | May 2009 | WO |
WO-2009066105 | May 2009 | WO |
WO-2009071924 | Jun 2009 | WO |
WO-2009089390 | Jul 2009 | WO |
WO-2009095170 | Aug 2009 | WO |
WO-2009103031 | Aug 2009 | WO |
WO-2009124100 | Oct 2009 | WO |
WO-2009124125 | Oct 2009 | WO |
WO-2009126103 | Oct 2009 | WO |
WO-2009146441 | Dec 2009 | WO |
WO-2009151645 | Dec 2009 | WO |
WO-2009156984 | Dec 2009 | WO |
WO-2009158128 | Dec 2009 | WO |
WO-2010017484 | Feb 2010 | WO |
WO-2010021783 | Feb 2010 | WO |
WO-2010033574 | Mar 2010 | WO |
WO-2010033613 | Mar 2010 | WO |
WO-2010033769 | Mar 2010 | WO |
WO-2010039481 | Apr 2010 | WO |
WO-2010051068 | May 2010 | WO |
WO-2010051418 | May 2010 | WO |
WO-2010056977 | May 2010 | WO |
WO-2010093753 | Aug 2010 | WO |
WO-2010126444 | Nov 2010 | WO |
WO-2010142959 | Dec 2010 | WO |
WO-2010144089 | Dec 2010 | WO |
WO-2010147533 | Dec 2010 | WO |
WO-2011003163 | Jan 2011 | WO |
WO-2011068310 | Jun 2011 | WO |
WO-2011082461 | Jul 2011 | WO |
WO-2011087871 | Jul 2011 | WO |
WO-2011097361 | Aug 2011 | WO |
WO-2011097362 | Aug 2011 | WO |
WO-2011103890 | Sep 2011 | WO |
WO-2011115851 | Sep 2011 | WO |
WO-2011130542 | Oct 2011 | WO |
WO-2011130549 | Oct 2011 | WO |
WO-2011135285 | Nov 2011 | WO |
WO-2011135286 | Nov 2011 | WO |
WO-2011135287 | Nov 2011 | WO |
WO-2011144888 | Nov 2011 | WO |
WO-2011146535 | Nov 2011 | WO |
WO-2011148188 | Dec 2011 | WO |
WO-2011150529 | Dec 2011 | WO |
WO-2012028842 | Mar 2012 | WO |
WO-2012034238 | Mar 2012 | WO |
WO-2012038724 | Mar 2012 | WO |
WO-2012048179 | Apr 2012 | WO |
WO-2012088572 | Jul 2012 | WO |
WO-2012095245 | Jul 2012 | WO |
WO-2012131237 | Oct 2012 | WO |
WO-2012140180 | Oct 2012 | WO |
WO-2012140378 | Oct 2012 | WO |
WO-2012142002 | Oct 2012 | WO |
WO-2012143665 | Oct 2012 | WO |
WO-2013006932 | Jan 2013 | WO |
WO-2013007973 | Jan 2013 | WO |
WO-2013010907 | Jan 2013 | WO |
WO-2013015827 | Jan 2013 | WO |
WO-2013019017 | Feb 2013 | WO |
WO-2013064852 | May 2013 | WO |
WO-2013083800 | Jun 2013 | WO |
WO-2013136181 | Sep 2013 | WO |
WO-2013149078 | Oct 2013 | WO |
WO-2014008348 | Jan 2014 | WO |
WO-2014016759 | Jan 2014 | WO |
WO-2014020440 | Feb 2014 | WO |
WO-2014020443 | Feb 2014 | WO |
WO-2014022440 | Feb 2014 | WO |
WO-2014108476 | Jul 2014 | WO |
WO-2014113253 | Jul 2014 | WO |
WO-2015022334 | Feb 2015 | WO |
WO-2015022340 | Feb 2015 | WO |
Entry |
---|
Annex to the Communication, the Opposition of European Patent No. 2773383, dated Sep. 13, 2019, 17 pages. |
Appeal Decision for Japanese Patent Application No. 2013528768, dated Jul. 14, 2017, 20 pages. |
Brief Communication—Letter from the opponent of the Patent, re the Opposition for European Patent No. 3146986, dated Feb. 3, 2022, 2 pages. |
Brief Communication—Letter from the opponent of the Patent, re the Opposition for European Patent No. 3146986, dated Jan. 26, 2022, 4 pages. |
Brief Communication—Letter from the Opponent, re the Opposition of European Patent No. 2773383, dated Mar. 24, 2021, 4 pages. |
Brief Communication—Letter from the Opponent, re the Opposition of European Patent No. 3326656, dated Oct. 14, 2021, 41 pages. |
Brief Communication—Letter from the Proprietor of the Patent, re the Opposition for European Patent No. 3146986, dated Dec. 15, 2021, 7 pages. |
Brief Communication—Letter from the Proprietor of the Patent, re the Opposition for Simmons & Simmons for European Patent No. 3146986, dated Feb. 7, 2022, 2 pages. |
Brief Communication—Letter from the Proprietor of the Patent, re the Opposition of European Patent No. 2773383, dated Mar. 24, 2021, 25 pages. |
Brief Communication of the Opposition Proceedings for European Patent No. 3326656, dated Aug. 25, 2021, 34 pages. |
Brief Communication of the Opposition Proceedings for European Patent No. 3326656, dated Jul. 14, 2022, 11 pages. |
British Standards Institution, “Sterilization of medical devices and packaging,” retrieved from URL: https://shop.bsigroup.com/en/Browse-By-Subject/Medical-Device-Standards/Sterilization-of-medical-devices-and-packaging/ onMar. 12, 2020, 1 page. |
Communication of further notices of opposition pursuant to Rule 79(2) EPC for the European Patent No. 3146986, dated Aug. 20, 2020, 2 pages. |
Consolidated List of Cited Opposition Documents of the European Patent No. 2773383, dated Jan. 23, 2020, 1 page. |
Decision by a different Opposition Division for European Application No. 11802142.7, dated Sep. 24, 2021, 22 pages. |
Decision by Opposition Division re the Opposition of European Patent No. 2773383, revoking a patent with claims essentially corresponding to the claims presented in the new requests dated Sep. 24, 2021, 22 pages. |
Decision of Rejection dated Apr. 4, 2016 for Japanese Application No. 2013-528768, 9 pages. |
Decision revoking the European Patent (Art. 101 (3)(b) EPC) for European Patent No. 2773383, dated Sep. 24, 2021, 56 pages. |
Dempsey D.J., “Sterilization of Medical Devices: A Review,” Journal of Biomaterials Applications, Jan. 1989, vol. 3, pp. 454-523. |
Diels K., et al., “Leybold Vacuum Handbook,”Pergamon Press, 1966, 10 pages. |
European Extended Search Report and Office Action dated Feb. 14, 2017 for European Application No. 16193508.5. |
Extent of the Opposition and Request for European Patent No. 3326656, dated Feb. 12, 2021, 58 pages. |
Hoxey E., “Sterilization—Regulatory Requirements and Supporting Standards,” BSI National Standards Body, Medical Device White Paper Series, Publication Date Unknown, 27 pages. |
Information about the result of oral proceedings for European Patent No. 2773383, dated May 19, 2021, 2 pages. |
Interlocutory Decision in Opposition and Accompanying Items for European Patent No. 3146986, dated Feb. 23, 2022, 28 pages. |
International Preliminary Report on Patentability for Application No. PCT/GB2011/051745, dated Mar. 26, 2013, 7 pages. |
International Search Report and Written Opinion for Application No. PCT/IB2011/002943, dated Jan. 28, 2013, 24 pages. |
International Search Report for Application No. PCT/GB2011/051745, dated Feb. 2, 2012, 5 pages. |
KCI, Inc., “Acti V.A.C. Therapy System,” User Manual, Sep. 2007, 64 pages. |
KCI Licensing Inc, “Prevena™ Incision Management System,” Clinician Guide, Instructions for Use, 390061 Rev C, Nov. 2009, 12 pages.<gdiv class=“ginger-extension-definitionpopup” style=“left: 525.701px; top: 16.8889px; z-index: 2147483646; display: none;”><gdiv class=“ginger-dp”> <gdiv class=“ginger-dp-content”> <gdiv class=“ginger-dp-title”><gspan id=“dp-title”>January</gspan></gdiv> <gdiv class=“ginger-dp-description” id=“dp-description”>the first month of the year; begins 10 days after the winter solstice</gdiv> <gdiv class=“ginger-dp-more”>More <gspan>(Definitions, Synonyms, Translation)</gspan><gdiv>.</gdiv></gdiv><gdiv>. |
KCI Licensing, Inc., “V.A.C.Via™—Negative Pressure Wound Therapy System,” 7-Day V.A.C.® Therapy System, Instructions for Use, 360063 Rev B, Aug. 2010, 24 pages. |
KCI to Launch the V.A.C.VIA™, an Advanced Mobile Healing Technology, dated Apr. 26, 2010, 3 pages. |
KCI USA Inc., “SNAP™ Therapy System,” Instructions for Use, SNAP™ Therapy Cartridge, Jul. 2016, 2 pages. |
Kendall ULTEC Hydrocolloid Dressing (4x4“),” Product Ordering Page, web page downloaded on Jul. 13, 2014, 1 page. |
Kinetic Concepts, Inc. Q2 2010 Earnings Call Transcript, dated Jul. 27, 2010, 25 pages. |
Kinetic Concepts Inc., V.A.C. Therapy, dated Jan. 11, 2011, 2 pages. |
Letter of the Opponent for the European Patent No. 2773383, dated Jun. 15, 2022, 57 pages. |
Letter relating to the Appeal Procedure for the Opposition of the European Patent No. 2618860, dated Dec. 23, 2019, 5 pages. |
Maintenance of the patent with the documents specified in the final decision, re the opposition of European patent No. EP3146986, mailed on Jun. 7, 2022, 1 page. |
Martin L.H., et al., “A Manual of Vacuum Practice,” Melbourne University Press, first published 1947, reprinted 1948, 12 pages. |
Matsunaga K., et al., “Gas Permeability of Thermoplastic Polyurethane Elastomers,” Polymer Journal, Jun. 2005, vol. 37, No. 6, pp. 413-417. |
Morcos A.C., “Voice Coil Actuators & Their Use in Advanced Motion Control Systems,” Motion, Jul./Aug. 1995, pp. 25-27. |
“SNAP™—Wound Care System,” Instructions for Use (L20897), Dec. 9, 2007, 16 pages. |
Notice of Communication of amended entries concerning the representative (R. 143(1 )(h) EPC) and enclosed letter from the proprietor of the patent dated Jan. 8, 2021 for the European Patent No. 3146986, dated Jan. 20, 2021, 6 pages. |
Notice of Opposition—Statement of Facts and Arguments for the European Patent No. 2618860, dated Aug. 26, 2016, 9 pages. |
Notice of Opposition—Statement of Facts and Evidence for the European Patent No. 2773383, dated Dec. 28, 2018, 20 pages. |
Notice of Opposition to a European Patent No. 2618860, dated Mar. 16, 2016, 5 pages. |
Notice of Reasons for Rejection for Japanese Patent Application No. 2016153604, dated Jul. 3, 2017, 4 pages. |
Observations filed by Third Party for the European Patent No. 2773383, dated Jan. 28, 2020, 7 pages. |
Office Action and Search Report dated Sep. 1, 2015 for Chinese Application No. 201180055731.0, 14 pages. |
Office Action dated Jul. 19, 2016 for Chinese Application No. 201180055731.0, 11 pages. |
Office Action dated Jul. 27, 2015, for Japanese Application No. 2013-528768. |
Office Action dated Apr. 28, 2017 for Canadian Application No. 2811718, 3 pages. |
Opponent Arguments for the European Patent No. EP2773383, dated Jan. 28, 2020, 25 pages. |
Opponent's Statement of Facts and Arguments for the European Patent No. 3146986, dated Jul. 30, 2020, 6 pages. |
Opponent Submissions Prior to Oral Proceedings for Opposition to European Patent No. 2618860, dated Sep. 14, 2017, 4 pages. |
Opponent's Written Submission in Preparation for the Oral Proceedings, opposition of the European Patent No. 2773383, dated Mar. 16, 2020, 8 pages. |
Opponent's Written Submission in Preparation for the Oral Proceedings, the Opposition of European Patent No. 3146986, dated Dec. 7, 2021, 1 page. |
Opposition—Statement of Facts and Evidence for Opposition for the European Patent No. 2618860, filed on Mar. 16, 2016, 9 pages. |
Opposition by KCI Licensing Inc. to EP2708216 Smith & Nephew Inc., Submitted as Evidence in Support of tile Appeal re European Patent No. 2618860, dated Apr. 5, 2018, 5 pages. |
Oral Proceeding Minutes, Decision Rejecting the Opposition, and Grounds of Decision, re European Patent No. EP2618860, dated Jan. 19, 2018, 11 pages. |
Park S.M., et al., “Design and Analysis of VCA for Fuel Pump in Automobile,” World of Academy of Science, Engineering and Technology, vol. 80, 2011, pp. 573-576. |
Patentee Final Written Submissions in Advance of Oral Proceedings for Opposition to European Patent No. 2618860, dated Sep. 13, 2017, 4 pages. |
Preliminary Opinion of the Opposition Division for the European Patent No. 2618860, dated Dec. 22, 2016, 5 pages. |
Proprietor Arguments for the European Patent No. EP2773383, dated Jan. 28, 2020, 32 pages. |
Proprietor Reply to Statement of Opponent's Grounds of Appeal, re European Patent No. 2618860, dated Sep. 28, 2018, 38 pages. |
Proprietor's Written Submission in Preparation for the Oral Proceedings, opposition of European Patent No. 2773383, dated Mar. 18, 2020, 9 pages. |
Proprietor's Written Submission in the Opposition Proceedings for European Patent No. 3326656, dated Jul. 13, 2022, 65 pages. |
Protz K., “Modern Wound Dressings Support the Healing Process,” Wound care: Indications and Application, Geriatrie Journal, Apr. 2005, pp. 3333-3339 (17 pages with English translation). |
Rangwala A.S., “Reciprocating Machinery Dynamics,” New Age International Publishers, ISBN:81-224-1813-9, 2006, 6 pages. |
Reply of the Patent Proprietor to the Notice of the Opposition, the Opposition of European Patent No. 2773383, dated Jun. 3, 2019, 11 pages. |
Smith & Nephew, “Smith & Nephew Introduces the First, Pocket-sized, Canister Free, Portable Negative Wound Therapy System in the EU,” Cision PR Newswire press release, May 25, 2011, 4 pages. |
Smith & Nephew, “Smith & Nephew Introduces the First, Pocket-sized, Canister Free, Portable Negative Wound Therapy System in the EU,” Press Release, May 25, 2011, 3 pages. |
Smith & Nephew, “Patient Home Care Information,” PICO booklet, Mar. 2011, 12 pages. |
Smith & Nephew, “PICO—The Early Studies,” Case Study booklet, Mar. 2011, 24 pages. |
Smith & Nephew, “PICO Single Use Negative Pressure Wound Therapy System,” Spiral Booklet, Jul. 2011, 11 pages.<gdiv class=“ginger-extension-definitionpopup” style=“left: 405.424px; top: 16.8889px; z-index: 2147483646; display: none;”xgdiv class=“ginger-dp”> <gdiv class=“ginger-dp-content”> <gdiv class=“ginger-dp-title”><gspan id=“dp-title”>March</gspan></gdiv> <gdiv class=“ginger-dp-description” id=“dp-description”>the act of marching; walking with regular steps (especially in a procession of some kind)</gdiv> <gdiv class=“ginger-dp-more”>More <gspan>(Definitions, Synonyms, Translation)</gspan></gdiv>.</gdiv></gdiv></gdiv>. |
Smith & Nephew, “Pictures of Pump Assembly of Device Obtained for the application No. 170203441.5,” Oct. 28, 2020, 28 pages. |
Snap™ Therapy System, “Monograph,” KCI, 3 pages. |
Statement of Grounds of Appeal filed by proprietor for European patent No. 2773383, mailed on Feb. 2, 2022, 53 pages. |
Statement of Opponent's Grounds of Appeal for European Patent No. EP2618860, dated May 18, 2018, 4 pages. |
Summons to Attend Oral Proceedings pursuant to Rule 115(1) for European Patent No. 3326656, mailed on Dec. 16, 2021, 17 pages. |
Summons to attend oral proceedings pursuant to Rule 115(1) EPC for European Patent No. 2773383, mailed on Sep. 30, 2020, 19 pages. |
Summons to attend oral proceedings pursuant to Rule 115(1) EPC for the European Patent No. 3146986, mailed on Apr. 19, 2021, 10 pages. |
Summons to Attend Oral Proceedings pursuant to rule 115(1) EPC for Application No. 11802142.7, mailed on Jun. 3, 2020, 20 pages. |
The Constructor, “Reciprocating Pump—Components, Working and Uses,” Retrieved from https://theconstructor.org/practical-guide/reciprocating-pumpcomponents-working-uses/2914/, on Jan. 21, 2020, 4 pages. |
Trademark/Service Mark Statement of Use (15 U.S.C. Section 1051(d)) for V.A.C.VIA, dated Sep. 22, 2010, 6 pages. |
U.S. Office Action dated Aug. 15, 2013 for U.S. Appl. No. 13/824,982, 14 pages. |
Wikipedia, “Pump,” retrieved from https://en.wikipedia.org/wiki/Pump on Mar. 13, 2020, 11 pages. |
Written Submission by the Opponent for Opposition of European Patent No. EP2773383, dated Jul. 22, 2020, 2 pages. |
Written Submission by the Proprietor for Opposition of European Patent No. EP2773383, dated Jul. 22, 2020, 15 pages. |
Communication pursuant to Rule 82(2) EPC for Application No. 16193508.5, dated Jun. 14, 2022, 4 pages. |
Termination of the Opposition Proceedings with Maintenance of European Patent No. 3146986, dated Jul. 8, 2022, 1 page. |
Number | Date | Country | |
---|---|---|---|
20220273861 A1 | Sep 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17339464 | Jun 2021 | US |
Child | 17747874 | US | |
Parent | 16141701 | Sep 2018 | US |
Child | 17339464 | US | |
Parent | 15941908 | Mar 2018 | US |
Child | 16141701 | US | |
Parent | 14972734 | Dec 2015 | US |
Child | 15941908 | US | |
Parent | 14256658 | Apr 2014 | US |
Child | 14972734 | US | |
Parent | 13824982 | US | |
Child | 14256658 | US |